IT staff are likely to escape job cuts announced by AstraZeneca and Glaxosmithkline (GSK).
The pharmaceuticals firms have both announced worldwide job cuts, with the former losing 8,000 on top of 15,000 earlier cuts, and GSK expected to cut up to 3,000.
SourceInsider's view: I'm breathing easier already.
Much better idea to get rid of all those R&D folks!
1 comment:
Plus it doesn't take as many people to manipulate data as to generate it.
Post a Comment